Total Payments
$195,917
2024 Payments
$2,783
Companies
29
Transactions
178
Medicare Patients
2,000
Medicare Billing
$210,693
Payment Breakdown by Category
Consulting$165,919 (84.7%)
Travel$12,916 (6.6%)
Other$10,266 (5.2%)
Food & Beverage$5,591 (2.9%)
Research$1,189 (0.6%)
Education$35.39 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $165,919 | 9 | 84.7% |
| Travel and Lodging | $12,916 | 38 | 6.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,200 | 12 | 5.2% |
| Food and Beverage | $5,591 | 114 | 2.9% |
| Unspecified | $1,189 | 1 | 0.6% |
| Grant | $66.43 | 1 | 0.0% |
| Education | $35.39 | 3 | 0.0% |
Payments by Type
General
$194,728
177 transactions
Research
$1,189
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardiovascular Systems Inc. | $153,430 | 11 | $0 (2017) |
| Biosense Webster, Inc. | $15,332 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,472 | 17 | $0 (2022) |
| Medtronic Vascular, Inc. | $4,819 | 17 | $0 (2019) |
| Eli Lilly and Company | $1,820 | 10 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,709 | 12 | $0 (2018) |
| Amgen Inc. | $1,457 | 13 | $0 (2023) |
| CSL Behring | $1,327 | 8 | $0 (2018) |
| Medical Device Business Services, Inc. | $1,090 | 8 | $0 (2017) |
| Edwards Lifesciences Corporation | $893.71 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,783 | 20 | Eli Lilly and Company ($1,820) |
| 2023 | $774.35 | 11 | HeartFlow, Inc. ($249.63) |
| 2022 | $304.77 | 4 | AstraZeneca Pharmaceuticals LP ($263.89) |
| 2021 | $4,541 | 9 | AstraZeneca Pharmaceuticals LP ($4,465) |
| 2020 | $5,746 | 10 | AstraZeneca Pharmaceuticals LP ($5,703) |
| 2019 | $4,713 | 24 | Medtronic Vascular, Inc. ($4,563) |
| 2018 | $7,955 | 35 | Biosense Webster, Inc. ($5,110) |
| 2017 | $169,099 | 65 | Cardiovascular Systems Inc. ($153,430) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | Eli Lilly and Company | — | — | In-kind items and services | $1,188.91 | Research |
| Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | ||||||
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $320.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $118.73 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $51.01 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $32.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $15.00 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 06/17/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 06/13/2024 | Biosense Webster, Inc. | NA (Device), NUVISION ICE CATHETER | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Ultrasound Catheters | ||||||
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: DIABETES | ||||||
| 04/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $371.74 | General |
| 04/04/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $105.00 | General |
| 04/04/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $82.86 | General |
| 04/03/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $151.97 | General |
| 03/21/2024 | Biosense Webster, Inc. | Soundstar (Device) | Food and Beverage | In-kind items and services | $124.79 | General |
| Category: Ultrasound Catheters | ||||||
| 01/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Cardiology | ||||||
| 11/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiology | ||||||
| 11/02/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Cardiology | ||||||
| 09/12/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/08/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $164.39 | General |
| Category: Stents | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | Eli Lilly and Company | $1,189 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 640 | 860 | $224,303 | $67,812 |
| 2022 | 7 | 428 | 609 | $158,086 | $48,006 |
| 2021 | 6 | 426 | 595 | $168,455 | $49,664 |
| 2020 | 8 | 506 | 654 | $181,570 | $45,211 |
Total Patients
2,000
Total Services
2,718
Medicare Billing
$210,693
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 241 | $72,300 | $23,696 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 329 | $68,103 | $22,571 | 33.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 42 | 42 | $35,238 | $8,380 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $20,884 | $5,645 | 27.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 58 | 58 | $12,760 | $3,432 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $9,801 | $2,882 | 29.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 102 | 111 | $5,217 | $1,206 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 201 | 344 | $71,208 | $23,084 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 124 | $37,200 | $11,953 | 32.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 25 | 26 | $21,814 | $5,116 | 23.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 40 | 41 | $9,020 | $2,519 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $8,613 | $2,210 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,356 | $1,785 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 31 | $3,875 | $1,339 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 191 | 326 | $98,427 | $30,813 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 125 | $25,827 | $8,037 | 31.1% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels and left lower heart including imaging interpretation and supervision and injection | Facility | 2021 | 25 | 25 | $22,235 | $5,044 | 22.7% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2021 | 48 | 48 | $10,676 | $2,956 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $8,738 | $2,259 | 25.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 46 | 52 | $2,552 | $554.64 | 21.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 153 | 234 | $70,902 | $18,778 | 26.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 146 | 194 | $39,964 | $9,154 | 22.9% |
| 92928 | Catheter insertion of stents in major coronary artery or branch, accessed through the skin | Facility | 2020 | 12 | 12 | $20,868 | $5,629 | 27.0% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 28 | 28 | $25,844 | $5,324 | 20.6% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2020 | 32 | 32 | $7,168 | $2,055 | 28.7% |
About Dr. Nabil Dib, MD
Dr. Nabil Dib, MD is a Interventional Cardiology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508867383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nabil Dib, MD has received a total of $195,917 in payments from pharmaceutical and medical device companies, with $2,783 received in 2024. These payments were reported across 178 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($165,919).
As a Medicare-enrolled provider, Dib has provided services to 2,000 Medicare beneficiaries, totaling 2,718 services with total Medicare billing of $210,693. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Gilbert, AZ
- Active Since 08/03/2005
- Last Updated 12/06/2024
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1508867383
Products in Payments
- Coronary Orbital Atherectomy System (Device) $153,315
- FARXIGA (Drug) $10,329
- Resolute (Device) $4,497
- MK-1242 (Drug) $1,709
- Carto 3 System (Device) $1,090
- ENTRESTO (Drug) $651.99
- Impella (Device) $312.85
- FFRct (Device) $304.70
- WATCHMAN (Device) $278.23
- Repatha (Biological) $245.86
- CoreValve Evolut (Device) $207.02
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $183.25
- RESOLUTE ONYX (Device) $164.39
- Xience V coronary stent system (Device) $143.07
- Cook Medical Catheters (Device) $135.43
- Soundstar (Device) $124.79
- WATCHMAN DEVICE (Device) $110.09
- XARELTO (Drug) $102.45
- Accessories (Structural Intervention) (Device) $97.68
- AMPLATZER Occluders (Device) $95.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.